Prognostic role of C-reactive protein and Interleukin-6 in dialysis patients: A systematic review and meta-analysis

Journal of Nephrology

Volumn 26, Issue 2, 2013, Pages 243-253

  Zhang, Wei ^a,b   He, Jing ^a   Zhang, Fengmei ^a   Huang, Chengjin ^c   Wu, Ying ^a   Han, Yijie ^a   Zhao, Yulan ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

C reactive protein; Dialysis; Interleukin 6; Prognosis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL PRACTICE; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; META ANALYSIS; PERITONEAL DIALYSIS; PREDICTION; PREDICTIVE VALUE; PROGNOSIS; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 84875330920     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000169     Document Type: Review

References (136)

1. El Nahas M. The global challenge of chronic kidney disease. Kidney Int. 2005;68:2918-2929.
2. Meuwese CL, Stenvinkel P, Dekker FW, et al. Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol. 2011;7:166-176.
3. Spiegel BM, Melmed G, Robbins S, et al. Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol. 2008;3:1759-1768.
4. Badiou S, Cristol JP, Jaussent I, et al. Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination. Clin J Am Soc Nephrol. 2008;3:423-430.
5. Stenvinkel P. The role of inflammation in the anaemia of endstage renal disease. Nephrol Dial Transplant. 2001;16(Suppl 7):36-40.
6. Balafa O, Halbesma N, Struijk DG, et al. Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011;6: 561-566.
7. Barreto DV, Barreto FC, Liabeuf S, et al. Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease. Kidney Int. 2010;77:550-556.
8. Beddhu S, Cheung AK, Larive B, et al. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007;17:372-380.
9. Chen HY, Chiu YL, Hsu SP, et al. Elevated C-reactive protein level in hemodialysis patients with moderate/severe uremic pruritus: a potential mediator of high overall mortality. QJM. 2010;103:837-846.
10. Shoji T, Masakane I, Watanabe Y, et al. Elevated non-highdensity lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:1112-1120.
11. Kawaguchi T, Tong L, Robinson BM, et al. C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract. 2011;117:c167-c178.
12. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627-636.
13. Zoccali C, Mallamaci F, Tripepi G, et al. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;70:523-528.
14. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
15. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
16. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315: 629-634.
17. Akdag I, Yilmaz Y, Kahvecioglu S, et al. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract. 2008;108:c99-c105.
18. Blaha V, Mistrik E, Dusilova-Sulkova S, et al. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem. 2009;42:996-1000.
19. Lam MF, Leung JC, Lam CW, et al. Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int. 2008;28:377-384.
20. Stojanov MD, Jovicic DM, Djuric SP, et al. Butyrylcholinesterase activity and mortality risk in hemodialysis patients: comparison to hsCRP and albumin. Clin Biochem. 2009;42: 22-26.
21. Ajiro J, Alchi B, Narita I, et al. Mortality predictors after 10 years of dialysis: a prospective study of Japanese hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:653-660.
22. Akgul A, Bilgic A, Sezer S, et al. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients. J Ren Nutr. 2008;18:338-346.
23. Amabile N, Guerin AP, Tedgui A, et al. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant. 2011. [Epub ahead of print]
24. Ates K, Ates A, Ekmekci Y, et al. The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int. 2005;25:256-268.
25. Avram MM, Fein PA, Paluch MM, et al. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Adv Perit Dial. 2005;21:154-158.
26. Bayes B, Pastor MC, Bonal J, et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up. Nephrol Dial Transplant. 2006;21:984-990.
27. Bayes B, Pastor MC, Bonal J, et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant. 2003;18:106-112.
28. Bazeley J, Bieber B, Li Y, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2452-2461.
29. Boger CA, Gotz A, Stubanus M, et al. C-reactive protein as predictor of death in end-stage diabetic nephropathy: role of peripheral arterial disease. Kidney Int. 2005;68:217-227.
30. Boulier A, Jaussent I, Terrier N, et al. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Nephrol Dial Transplant. 2004;19:2313-2318.
31. Breit SN, Carrero JJ, Tsai VW, et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant. 2012;27:70-75.
32. Carrero JJ, Qureshi AR, Axelsson J, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr. 2007;85:695-701.
33. Chauveau P, Level C, Lasseur C, et al. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study. J Ren Nutr. 2003;13:137-143.
34. Chen KH, Lin-Tan DT, Huang WH, et al. Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis. Kidney Blood Press Res. 2008;31:143-151.
35. Chou CY, Kuo HL, Yung YF, et al. C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Blood Purif. 2006;24:342-346.
36. Chung SH, Heimburger O, Stenvinkel P, et al. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant. 2003;18:590-597.
37. Cianciolo G, La Manna G, Coli L, et al. 5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients. Am J Nephrol. 2008;28:941-948.
38. de Mutsert R, Grootendorst DC, Indemans F, et al. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19:127-135.
39. deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353-359.
40. Etter C, Straub Y, Hersberger M, et al. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J. 2010;31:354-359.
41. Fein PA, Fazil I, Rafiq MA, et al. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients. Adv Perit Dial. 2006;22:2-6.
42. Fukuoka K, Nakao K, Morimoto H, et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology (Carlton). 2008;13:278-283.
43. Genovesi S, Valsecchi MG, Rossi E, et al. Sudden death and associated factors in a historical cohort of chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:2529-2536.
44. Guo Q, Barany P, Qureshi AR, et al. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients. Am J Nephrol. 2009;29:516-523.
45. Han SS, Ahn JM, Chin HJ, et al. Impact of C-reactive protein and pulse pressure evaluated at the start of peritoneal dialysis on cardiovascular events in the course of treatment with peritoneal dialysis. Perit Dial Int. 2010;30:300-310.
46. Hase H, Tsunoda T, Tanaka Y, et al. Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int. 2006;70: 1142-1148.
47. Herzig KA, Purdie DM, Chang W, et al. Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2001;12:814-821.
48. Hickman PE, McGill DA, Talaulikar G, et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J. 2009;39:812-818.
49. Hocher B. Different Impact of Biomarkers as Mortality Predictors among Diabetic and Nondiabetic Patients Undergoing Hemodialysis. J Am Soc Nephrol. 2003;14:2329-2337.
50. Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47:139-148.
51. Hsu CW, Lin JL, Lin-Tan DT, et al. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial. 2010;14:552-559.
52. Hung CY, Chen YA, Chou CC, et al. Nutritional and inflammatory markers in the prediction of mortality in Chinese hemodialysis patients. Nephron Clin Pract. 2005;100:c20-c26.
53. Ignacy W, Chudek J, Adamczak M, et al. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease--a follow-up study. Nephron Clin Pract. 2005;101: c18-c24.
54. Iseki K, Tozawa M, Yoshi S, et al. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956-1960.
55. Ishii H, Kumada Y, Toriyama T, et al. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. J Vasc Surg. 2010;52:854-859.
56. Ishii H, Toriyama T, Aoyama T, et al. Prognostic values of Creactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Circ Cardiovasc Interv. 2009;2:513-518.
57. Kalantar-Zadeh K, Kopple JD, Humphreys MH, et al. Comparing outcome predictability of markers of malnutritioninflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004;19:1507-1519.
58. Kanaan N, Goffin E, Maisin D, et al. CRP measurement: does the assay matter in hemodialysis patients? Clin Nephrol. 2008;70:503-507.
59. Kanwar M, Hashem M, Rosman H, et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol. 2006;98:1283-1287.
60. Kato A, Takita T, Furuhashi M, et al. Blood monocyte count is a predictor of total and cardiovascular mortality in hemodialysis patients. Nephron Clin Pract. 2008;110:c235-c243.
61. Kessler M, Zannad F, Lehert P, et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study. Nephrol Dial Transplant. 2007;22:3573-3579.
62. Kim KM, Kim SS, Kim H, et al. Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology. Clin Nephrol. 2011;75:458-465.
63. Kobayashi I, Ishimura E, Kato Y, et al. Geriatric Nutritional Risk Index, a simplified nutritional screening index, is a significant predictor of mortality in chronic dialysis patients. Nephrol Dial Transplant. 2010;25:3361-3365.
64. Korevaar JC, van Manen JG, Dekker FW, et al. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol. 2004;15:2916-2922.
65. Koulouridis E, Tzilianos M, Katsarou A, et al. Homocysteine and C-reactive protein levels in haemodialysis patients. Int Urol Nephrol. 2001;33:207-215.
66. Krane V, Winkler K, Drechsler C, et al. Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. Kidney Int. 2008;74:1461-1467.
67. Lentine KL, Parsonnet J, Taylor I, et al. Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin Exp Nephrol. 2006;10:55-62.
68. Lin CJ, Wu CJ, Pan CF, et al. Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. Nephrol Dial Transplant. 2010;25:3693-3700.
69. Lindner G, Doberer E, Vychytil A, et al. Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis. Wien Klin Wochenschr. 2009;121: 391-397.
70. Lin-Tan DT, Lin JL, Wang LH, et al. Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis. J Am Soc Nephrol. 2007;18:2385-2391.
71. Lorenzen JM, David S, Richter A, et al. TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study. Nephrol Dial Transplant. 2011;26:1421-1424.
72. Mallamaci F, Tripepi G, Cutrupi S, et al. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int. 2005;67:2330-2337.
73. Meerwaldt R, Hartog JW, Graaff R, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16:3687-3693.
74. Mimura I, Nishi H, Nishi T, et al. Malnutrition and inflammation determine prognosis of patients with CRS type 4. Blood Purif. 2011;31:276-280.
75. Morena M, Terrier N, Jaussent I, et al. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol. 2006;17:262-270.
76. Naganuma T, Sugimura K, Wada S, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol. 2002;22:437-444.
77. Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant. 2004;19:2803-2809.
78. Nishizawa Y, Shoji T, Kakiya R, et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl. 2003;S117-S120.
79. Noh H, Lee SW, Kang SW, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 1998;18:387-394.
80. Noori N, Kovesdy CP, Dukkipati R, et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol. 2011;33:157-167.
81. Ohtake T, Ishioka K, Honda K, et al. Impact of coronary artery calcification in hemodialysis patients: Risk factors and associations with prognosis. Hemodial Int. 2010;14:218-225.
82. Okuno S, Ishimura E, Kohno K, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant. 2009;24:571-577.
83. Ozen KP, Asci G, Gungor O, et al. Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol. 2011;33:305-312.
84. Pachaly MA, do Nascimento MM, Suliman ME, et al. Interleukin-6 is a better predictor of mortality as compared to Creactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients. Blood Purif. 2008;26:204-210.
85. Paniagua R, Frias Y, de Ventura MJ, et al. C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int. 2003;23:132-137.
86. Panichi V, Rosati A, Bigazzi R, et al. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrol Dial Transplant. 2011;26:2641-2648.
87. Parekh RS, Plantinga LC, Kao WH, et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int. 2008;74:1335-1342.
88. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, et al. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274-284.
89. Pupim LB, Caglar K, Hakim RM, et al. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int. 2004;66:2054-2060.
90. Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 2002; 13(Suppl 1):S28-S36.
91. Racki S, Zaputovic L, Mavric Z, et al. C-reactive protein is a strong predictor of mortality in hemodialysis patients. Ren Fail. 2006;28:427-433.
92. Rao M, Li L, Tighiouart H, et al. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant. 2008;23:2619-2628.
93. Roberts MA, Thomas MC, Fernando D, et al. Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis. Nephrol Dial Transplant. 2006;21:1611-1617.
94. Satomura A, Endo M, Fujita T, et al. Serum mannose-binding lectin levels in maintenance hemodialysis patients: impact on all-cause mortality. Nephron Clin Pract. 2006;102:c93-c99.
95. Schwedler SB, Metzger T, Schinzel R, et al. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int. 2002;62:301-310.
96. Scott B, Deman A, Peeters P, et al. Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients. Nephrol Dial Transplant. 2003;18:737-742.
97. Selim G, Stojceva-Taneva O, Spasovski G, et al. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up. Nephron Clin Pract. 2011;119:c162-c170.
98. Sengul S, Arat Z, Ozdemir FN. Renal amyloidosis is associated with increased mortality in hemodialysis patients. Artif Organs. 2004;28:846-852.
99. Simic-Ogrizovic S, Dopsaj V, Bogavac-Stanojevic N, et al. Serum Amyloid-A Rather Than C-Reactive Protein Is a Better Predictor of Mortality in Hemodialysis Patients. Tohoku J Exp Med. 2009;219:121-127.
100. Snaedal S, Heimburger O, Qureshi AR, et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis. 2009;53:1024-1033.
101. Spiegel DM, Raggi P, Smits G, et al. Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant. 2007;22:3568-3572.
102. Spinar J, Ludka O, Dusek L, et al. Neurohumoral activity, heart failure and prognosis in patients with end-stage renal disease treated by hemodialysis. Kidney Blood Press Res. 2007;30:347-357.
103. Spittle MA, Hoenich NA, Handelman GJ, et al. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001;38:1408-1413.
104. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005;67:2383-2392.
105. Stojanovic M, Stojanovic D, Stefanovic V. The impact of malnutrition on mortality in patients on maintenance hemodialysis in Serbia. Artif Organs. 2008;32:398-405.
106. Suliman M, Stenvinkel P, Qureshi AR, et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant. 2007;22:209-217.
107. Szeto CC, Chow KM, Kwan BC, et al. New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis. 2007;49:524-532.
108. Terrier N, Jaussent I, Dupuy AM, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant. 2008;23:345-353.
109. Trape J, Perez A, Naval I, et al. Nt-proBNP in haemodialysis patients: a preliminary study. Scand J Clin Lab Invest. 2008;68:415-420.
110. Tripepi G, Mattace Raso F, Sijbrands E, et al. Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. Clin J Am Soc Nephrol. 2011;6:1714-1721.
111. Troyanov S, Hebert MJ, Masse M, et al. Soluble Fas: a novel predictor of atherosclerosis in dialysis patients. Am J Kidney Dis. 2003;41:1043-1051.
112. Tsirpanlis G, Boufidou F, Zoga M, et al. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients. Hemodial Int. 2009;13:197-204.
113. Vekic J, Zeljkovic A, Bogavac-Stanojevic N, et al. Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clin Biochem. 2011;44:635-641.
114. Wagner Z, Molnar M, Molnar GA, et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:294-300.
115. Wang AYM. Is a Single Time Point C-Reactive Protein Predictive of Outcome in Peritoneal Dialysis Patients? J Am Soc Nephrol. 2003;14:1871-1879.
116. Wanner C, Zimmermann J, Schwedler S, et al. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl. 2002;99-102.
117. Westhuyzen J, Mills K, Healy H. Predicting clinical outcomes in peritoneal dialysis patients using small solute modeling. Ann Clin Lab Sci. 2005;35:46-53.
118. Yen TH, Lin JL, Lin-Tan DT, et al. Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial. 2010;14:400-408.
119. Yeun JY, Levine RA, Mantadilok V, et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469-476.
120. Yoon SH, Choi NW, Yun SR. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease. Nephron Clin Pract. 2009;111:c1-c6.
121. Zalunardo NY, Rose CL, Ma IW, et al. Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis. Kidney Int. 2007;71:687-692.
122. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648-658.
123. Zoccali C, Mallamaci F, Tripepi G, et al. Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med. 2003;254:132-139.
124. Beberashvili I, Azar A, Sinuani I, et al. Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients. Nephrol Dial Transplant. 2010;25: 2662-2671.
125. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis. 1998;32:107-114.
126. Han SH, Choi HY, Kim DK, et al. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease. Am J Nephrol. 2009;29:129-135.
127. Hasuike Y, Nonoguchi H, Ito K, et al. Interleukin-6 is a predictor of mortality in stable hemodialysis patients. Am J Nephrol. 2009;30:389-398.
128. Kato A, Takita T, Furuhashi M, et al. Association between seroprevalence of anti-chlamydial antibodies and long-term cardiovascular mortality in chronic hemodialysis patients. Atherosclerosis. 2006;188:120-125.
129. Lowbeer C, Stenvinkel P, Pecoits-Filho R, et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med. 2003;253:153-160.
130. Pecoits-Filho R, Barany P, Lindholm B, et al. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant. 2002;17:1684-1688.
131. Wang AY, Lam CW, Chan IH, et al. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers. Nephrol Dial Transplant. 2009;24:3826-3833.
132. Wetmore JB, Lovett DH, Hung AM, et al. Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients. Nephrology (Carlton). 2008; 13:593-600.
133. Porazko T, Kuzniar J, Kusztal M, et al. IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant. 2009;24:589-596.
134. Scialla JJ, Plantinga LC, Kao WH, et al. Soluble P-selectin levels are associated with cardiovascular mortality and sudden cardiac death in male dialysis patients. Am J Nephrol. 2011;33:224-230.
135. Zoccali C, Tripepi G, Mallamaci F. Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J Am Soc Nephrol. 2006;17:S169-S173.
136. Cohen SD, Phillips TM, Khetpal P, et al. Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant. 2010;25:1239-1243.